WallStSmart

Garmin Ltd (GRMN)vsMesa Laboratories Inc (MLAB)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Garmin Ltd generates 2896% more annual revenue ($7.46B vs $249.13M). GRMN leads profitability with a 23.3% profit margin vs 2.7%. GRMN trades at a lower P/E of 26.9x. GRMN earns a higher WallStSmart Score of 64/100 (C+).

GRMN

Buy

64

out of 100

Grade: C+

Growth: 7.3Profit: 8.0Value: 3.3Quality: 9.0
Piotroski: 5/9Altman Z: 5.27

MLAB

Avoid

30

out of 100

Grade: F

Growth: 3.3Profit: 4.0Value: 5.7Quality: 5.5
Piotroski: 5/9Altman Z: 0.70
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

GRMNSignificantly Overvalued (-52.1%)

Margin of Safety

-52.1%

Fair Value

$135.80

Current Price

$236.57

$100.77 premium

UndervaluedFair: $135.80Overvalued
MLABUndervalued (+64.0%)

Margin of Safety

+64.0%

Fair Value

$253.18

Current Price

$104.38

$148.80 discount

UndervaluedFair: $253.18Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GRMN5 strengths · Avg: 9.0/10
Debt/EquityHealth
0.0210/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
5.2710/10

Safe zone — low bankruptcy risk

Profit MarginProfitability
23.3%9/10

Keeps 23 of every $100 in revenue as profit

Operating MarginProfitability
24.6%8/10

Strong operational efficiency at 24.6%

EPS GrowthGrowth
21.5%8/10

Earnings expanding 21.5% YoY

MLAB0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

GRMN2 concerns · Avg: 3.0/10
P/E RatioValuation
26.9x4/10

Moderate valuation

PEG RatioValuation
3.252/10

Expensive relative to growth rate

MLAB4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
2.6%4/10

2.6% revenue growth

Market CapQuality
$573.99M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
3.6%3/10

ROE of 3.6% — below average capital efficiency

Profit MarginProfitability
2.7%3/10

2.7% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : GRMN

The strongest argument for GRMN centers on Debt/Equity, Altman Z-Score, Profit Margin. Profitability is solid with margins at 23.3% and operating margin at 24.6%. Revenue growth of 14.2% demonstrates continued momentum.

Bull Case : MLAB

MLAB has a balanced fundamental profile.

Bear Case : GRMN

The primary concerns for GRMN are P/E Ratio, PEG Ratio.

Bear Case : MLAB

The primary concerns for MLAB are Revenue Growth, Market Cap, Return on Equity. A P/E of 85.9x leaves little room for execution misses. Thin 2.7% margins leave little buffer for downturns.

Key Dynamics to Monitor

GRMN profiles as a mature stock while MLAB is a value play — different risk/reward profiles.

GRMN carries more volatility with a beta of 0.96 — expect wider price swings.

GRMN is growing revenue faster at 14.2% — sustainability is the question.

GRMN generates stronger free cash flow (469M), providing more financial flexibility.

Bottom Line

GRMN scores higher overall (64/100 vs 30/100), backed by strong 23.3% margins and 14.2% revenue growth. MLAB offers better value entry with a 64.0% margin of safety. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Garmin Ltd

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Garmin Ltd. is an American multinational technology company with headquarters in Olathe, Kansas.

Visit Website →

Mesa Laboratories Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Europe, Asia, North America, and internationally. The company is headquartered in Lakewood, Colorado.

Want to dig deeper into these stocks?